Results 31 to 40 of about 11,294,687 (338)

COPD and Cardiovascular Disease

Pulmonology, 2019
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated.
André, S., Conde, B., Fragoso, E., Boléo-Tomé, J.P., Areias, Vanda, Cardoso, J.   +5 more
openaire   +7 more sources

NAFLD and cardiovascular diseases: a clinical review

Clinical Research in Cardiology, 2020
Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in Western countries and affects approximately 25% of the adult population. Since NAFLD is frequently associated with further metabolic comorbidities such as obesity, type
P. Kasper, Anna Martin, S. Lang, F. Kütting, T. Goeser, M. Demir, H. Steffen   +6 more
semanticscholar   +1 more source

Lipoxidation in cardiovascular diseases

Redox Biology, 2019
Lipids can go through lipid peroxidation, an endogenous chain reaction that consists in the oxidative degradation of lipids leading to the generation of a wide variety of highly reactive carbonyl species (RCS), such as short-chain carbonyl derivatives and oxidized truncated phospholipids.
Gianazza, Erica, Brioschi, Maura, Fernandez, Alma Martinez, Banfi, Cristina   +3 more
openaire   +3 more sources

Peri-implant diseases and metabolic syndrome components: a systematic review [PDF]

, 2018
OBJECTIVE: Metabolic syndrome (MetS) is defined as a spectrum of conditions associated with an increased risk of developing CVD and type 2 diabetes.
Letizia, C, Papi, P, Petramala, L, Pilloni, A, Pompa, G, Rosella, D, Saraceno, V   +6 more
core   +1 more source

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Clinical Research in Cardiology, 2020
Background Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection.
Bo Li, Jing Yang, Faming Zhao, L. Zhi, Xiqian Wang, Lin Liu, Zhaohui Bi, Yunhe Zhao   +7 more
semanticscholar   +1 more source

C-peptide: a predictor of cardiovascular mortality in subjects with established atherosclerotic disease [PDF]

, 2017
Aim: Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past ...
Ballanti, Marta, Cardellini, Marina, Cardolini, Iris, Davato, Francesca, Farcomeni, Alessio, Federici, Massimo, Grappasonni, Giulia, Guglielmi, Valeria, Ippoliti, Arnaldo, Menghini, Rossella, Morelli, Monica, Pecchioli, Chiara, Porzio, Ottavia, Rizza, Stefano   +13 more
core   +1 more source

Oxidative Stress in Cardiovascular Diseases

Antioxidants, 2020
Reactive oxygen species (ROS) are subcellular messengers in signal transductions pathways with both beneficial and deleterious roles. ROS are generated as a by-product of mitochondrial respiration or metabolism or by specific enzymes such as superoxide ...
E. Dubois-Deruy, V. Peugnet, A. Turkieh, F. Pinet   +3 more
semanticscholar   +1 more source

Pseudogenes in Cardiovascular Disease [PDF]

Frontiers in Molecular Biosciences, 2021
Cardiovascular disease is the main disease that affects human life span. In recent years, the disease has been increasingly addressed at the molecular levels, for example, pseudogenes are now known to be involved in the pathogenesis and development of cardiovascular diseases.
Songtao An, Dongchang Chen, Xi Wang, Wenbo Li, Hua Meng, Yanyan Qi   +5 more
openaire   +3 more sources

Gender-Related Differences in the Prevalence of Cardiovascular Disease Risk Factors and their Correlates in Urban Tanzania. [PDF]

, 2009
\ud Urban areas in Africa suffer a serious problem with dual burden of infectious diseases and emerging chronic diseases such as cardiovascular diseases (CVD) and diabetes which pose a serious threat to population health and health care resources ...
AA Motala, AB Swai, AC Perry, Alfa Muhihi, AR Walker, D Filmer, D Hu, D Lasky, D Spiegelman, DL Christensen, Donna Spiegelman, E Ford, E Sobngwi, E Sobngwi, Ellen Hertzmark, Enju Liu, H Schroder, H Schultz, HH Vorster, J Chalmers, J Koerselman, Jacob Mtabaji, JP Despres, Julia L Finkelstein, K Jagoe, K Tibazarwa, KG Alberti, KY Liang, M Njelekela, M Siervo, MA Van der Sande, Marina A Njelekela, ME Mendelsohn, MR Akpa, NCEP, Nuru L Mligiliche, P Bovet, P Pasquet, R Fuentes, Rose Mpembeni, S Mendis, SM Smith, TJ Aspray, W Willet, Wafaie W Fawzi, Walter C Willett, WC Chumlea, WHO, WT Friedewald   +48 more
core   +4 more sources

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Signal Transduction and Targeted Therapy
The immune response holds a pivotal role in cardiovascular disease development. As multifunctional cells of the innate immune system, macrophages play an essential role in initial inflammatory response that occurs following cardiovascular injury, thereby
Runkai Chen, Hongrui Zhang, Botao Tang, Yukun Luo, Yufei Yang, Xin Zhong, Sifei Chen, Xinjie Xu, Shengkang Huang, Canzhao Liu   +9 more
semanticscholar   +1 more source